Imaging Characteristics of Coexisting Metastatic Papillary Thyroid Cancer and Prostate Cancer on 18F-Fluciclovine and 68Ga-PSMA-11 PET/CT

被引：3
|
作者：
Lu, Yang [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Dept Nucl Med, Div Diagnost Imaging, 1400 Pressler St,Unit 1483, Houston, TX 77030 USA
来源：
CLINICAL NUCLEAR MEDICINE | 2022年 / 47卷 / 09期
关键词：
Ga-68-PSMA-11; PET; F-18-fluciclovine PET; thyroid cancer; prostate cancer; metastasis; TRANSPORT; ACID; EXPRESSION;
D O I：
10.1097/RLU.0000000000004156
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
A 76-year-old man with biopsy-proven metastatic papillary thyroid cancer in a mediastinal nodule status post total thyroidectomy is on surveillance. The patient also had prostate cancer and received prostatectomy and androgen deprivation treatment. An F-18-fluciclovine PET revealed avid lesions in the mediastinal nodule and a sclerotic focus at L5 with concurrent prostate-specific antigen level of 0.4 ng/mL. The L5 lesion was later biopsied and confirmed as metastasis from prostate cancer. A Ga-68-PSMA-11 PET 2 months later showed avid radiotracer uptake within L5 metastasis but not the mediastinal nodule. The patient received radiation therapy to the L5 lesion and responded well.
引用
收藏
页码：820 / 821
页数：2
相关论文
共 50 条
  • [1] Comparison of 68Ga-PSMA-11 PET/CT and 18F-Fluciclovine PET/CT in recurrent Prostate Cancer
    Ceci, F.
    Polverari, G.
    Gartmann, J.
    Fendler, W.
    Eiber, M.
    Herrmann, K.
    Czernin, J.
    Calais, J.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S150 - S150
  • [2] Oligodendroglioma in 68Ga-PSMA-11 and 18F-Fluciclovine PET/CT
    Pernthaler, Birgit
    Nazerani Hooshmand, Tina
    Igrec, Jasminka
    Kvaternik, Herbert
    Aigner, Reingard M.
    CLINICAL NUCLEAR MEDICINE, 2021, 46 (04) : E231 - E232
  • [3] 68GA-PSMA-11 PET/CT VS 18F-FLUCICLOVINE PET/CT: A CASE SERIES IN PROSTATE CANCER PATIENTS WITH BIOCHEMICAL RECURRENCE
    Elkhoury, Fuad
    Calais, Jeremie
    Czernin, Johannes
    Fendler, Wolfgang
    Herrmann, Ken
    Eiber, Matthias
    Ceci, Francesco
    Reiter, Robert
    Marks, Leonard
    JOURNAL OF UROLOGY, 2018, 199 (04): : E259 - E259
  • [4] A Prospective Head-to-Head Comparison of 18F-Fluciclovine With 68Ga-PSMA-11 in Biochemical Recurrence of Prostate Cancer in PET/CT
    Pernthaler, Birgit
    Kulnik, Roman
    Gstettner, Christian
    Salamon, Spela
    Aigner, Reingard M.
    Kvaternik, Herbert
    CLINICAL NUCLEAR MEDICINE, 2019, 44 (10) : E566 - E573
  • [5] PROSTATE CANCER 18F-fluciclovine PET or PSMA PET for prostate cancer imaging?
    Turkbey, Baris
    Choyke, Peter L.
    NATURE REVIEWS UROLOGY, 2020, 17 (01) : 9 - 10
  • [6] 18F-fluciclovine PET or PSMA PET for prostate cancer imaging?
    Baris Turkbey
    Peter L. Choyke
    Nature Reviews Urology, 2020, 17 : 9 - 10
  • [7] Re: A Prospective Head-to-Head Comparison of 18F-Fluciclovine With 68Ga-PSMA-11 in Biochemical Recurrence of Prostate Cancer in PET/CT
    Evangelista, Laura
    Sepulcri, Matteo
    CLINICAL NUCLEAR MEDICINE, 2020, 45 (04) : E219 - E220
  • [8] Comparison of 68Ga-PSMA-11 and 18F-Fluciclovine PET/CT in a Case Series of 10 Patients with Prostate Cancer Recurrence: Interesting, but Far from Definitive
    Denes, Bela
    Gardiner, Peter
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (05) : 860 - 860
  • [9] Prospective intra-patient comparison of 18F-Fluciclovine and 68Ga-PSMA-11 PET/CT in biochemical recurrence of prostate cancer after definitive therapy
    Pernthaler, B.
    Kvaternik, H.
    Kulnik, R.
    Gstettner, C.
    Aigner, R. M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2019, 46 (SUPPL 1) : S24 - S24
  • [10] Comparison of 68Ga-PSMA-11 and 18F-Fluciclovine PET/CT in a Case Series of 10 Patients with Prostate Cancer Recurrence: Prospective Trial Is on Its Way
    Calais, Jeremie
    Fendler, Wolfgang Peter
    Herrmann, Ken
    Eiber, Matthias
    Ceci, Francesco
    JOURNAL OF NUCLEAR MEDICINE, 2018, 59 (05) : 861 - 861
12345